DJIA 17,730.11 -27.80 -0.16%
NASDAQ 5,009.21 0.00 0.00%
S&P 500 2,076.78 -0.64 -0.03%
market minute promo

4.44 -0.03 (-0.67%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ARNA $4.44 -0.67%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $4.50
Previous Close $4.47
Daily Range $4.40 - $4.50
52-Week Range $3.26 - $6.28
Market Cap $1.1B
P/E Ratio -17.08
Dividend (Yield) $0.00 (0.0%)
Volume 1,349,038
Average Daily Volume 2,395,819
Current FY EPS -$0.51




Drug Makers

Arena Pharmaceuticals, Inc. (ARNA) Description

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Website:

News & Commentary Rss Feed

Obesity Statistics Take a Wrong Turn in This Latest Study

Obesity, the silent killer, costs the global economy $2 trillion annually. Find out what tactics could be used to help curb rising obesity levels.

Arena - Belviq Advertising Report For June

Arena Pharmaceuticals (ARNA): Today's Weak On High Volume Stock

3 Common Pitfalls Biotech Investors Need to Learn to Avoid

Here is a look at three common mistakes investors make when buying biotech stocks.

Arena Pharmaceuticals (ARNA) Flagged As Strong On High Volume

Orexigen: Contrave Sales Lead The Sector, But Need Improvement

Belviq Sales Remain Flat- Quarter Over Quarter Will Not Impress

The Anti-Obesity Sector In Q2 Is Not Looking Good

Vivus: Something You Would Want To Know About Qsymia

Vivus- Qsymia Sales Dip From Peak In Previous Week

See More ARNA News...

ARNA's Top Competitors

ARNA $4.44 (-0.67%)
Current stock: ARNA
AMGN $153.26 (-1.12%)
Current stock: AMGN
GILD $115.04 (-0.84%)
Current stock: GILD
BIIB $404.28 (-0.28%)
Current stock: BIIB